The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combined assessment of metabolic response and tumor infiltrating lymphocytes as a predictor of outcomes following neoadjuvant therapy for HER2-positive breast cancer: Results from the randomized PREDIX HER2 trial.
 
Alexios Matikas
Honoraria - Veracyte
 
Hemming Johansson
No Relationships to Disclose
 
Per Grybäck
No Relationships to Disclose
 
Judith Bjöhle
No Relationships to Disclose
 
Tobias Lekberg
No Relationships to Disclose
 
Hanna Fredholm
No Relationships to Disclose
 
Balazs Acs
No Relationships to Disclose
 
Ellinor Elinder
No Relationships to Disclose
 
Erika Isaksson-Friman
No Relationships to Disclose
 
Susanne Agartz
No Relationships to Disclose
 
Mats Hellstrom
No Relationships to Disclose
 
Ioannis Zerdes
No Relationships to Disclose
 
Johan Hartman
Leadership - Stratipath AB
Stock and Other Ownership Interests - Stratipath AB
Honoraria - Lilly; MSD; Pfizer
Research Funding - Cepheid (Inst); Cepheid (Inst); Novartis (Inst)
 
Jonas C. S. Bergh
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Other Relationship - UpToDate
 
Thomas Hatschek
Consulting or Advisory Role - Pfizer; Pierre Fabre
Research Funding - Pfizer (Inst); Roche (Inst)
 
Theodoros Foukakis
Honoraria - UpToDate
Consulting or Advisory Role - Exact Sciences; Novartis; Pfizer; Pfizer (Inst); Roche (Inst); Veracyte
Research Funding - Pfizer (Inst)